LITOSEEK Trademark

Trademark Overview


On Friday, December 22, 2023, a trademark application was filed for LITOSEEK with the United States Patent and Trademark Office. The USPTO has given the LITOSEEK trademark a serial number of 98328271. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 19, 2024. This trademark is owned by Novigenix SA. The LITOSEEK trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical laboratory services for the analysis of blood samples taken from patients; services for the testing of blood; medical laboratory services for the analysis of samples taken from patients; services for blood analysis being medical analysis services for diagnostic treatment purposes provided by medical laboratories

Pharmaceutical research services; clinical research in the fields of immunotherapy and drug development; medical and scientific research, namely, conducting, clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; blood analysis services for scientific research purposes

General Information


Serial Number98328271
Word MarkLITOSEEK
Filing DateFriday, December 22, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, November 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 24, 2024

Trademark Statements


Goods and ServicesMedical laboratory services for the analysis of blood samples taken from patients; services for the testing of blood; medical laboratory services for the analysis of samples taken from patients; services for blood analysis being medical analysis services for diagnostic treatment purposes provided by medical laboratories
Goods and ServicesPharmaceutical research services; clinical research in the fields of immunotherapy and drug development; medical and scientific research, namely, conducting, clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; blood analysis services for scientific research purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 22, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 22, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovigenix SA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressEpalinges 1066
CH

Party NameNovigenix SA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressEpalinges 1066
CH

Trademark Events


Event DateEvent Description
Friday, December 22, 2023NEW APPLICATION ENTERED
Friday, April 5, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 24, 2024ASSIGNED TO EXAMINER
Monday, July 29, 2024NON-FINAL ACTION E-MAILED
Monday, July 29, 2024NON-FINAL ACTION WRITTEN
Monday, July 29, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 15, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, August 15, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, August 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 4, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 24, 2024PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT